- Home
- RLX vs MIR Comparison
RLX vs MIR Comparison
Compare RLX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLX
- MIR
- Stock Information
- Founded
- RLX 2018
- MIR 2005
- Country
- RLX China
- MIR United States
- Employees
- RLX N/A
- MIR N/A
- Industry
- RLX Medicinal Chemicals and Botanical Products
- MIR Industrial Machinery/Components
- Sector
- RLX Health Care
- MIR Technology
- Exchange
- RLX Nasdaq
- MIR Nasdaq
- Market Cap
- RLX 3.7B
- MIR 3.8B
- IPO Year
- RLX 2021
- MIR N/A
- Fundamental
- Price
- RLX $2.43
- MIR $15.82
- Analyst Decision
- RLX Strong Buy
- MIR Strong Buy
- Analyst Count
- RLX 1
- MIR 4
- Target Price
- RLX $2.76
- MIR $19.25
- AVG Volume (30 Days)
- RLX 4.8M
- MIR 2.3M
- Earning Date
- RLX 03-14-2025
- MIR 02-11-2025
- Dividend Yield
- RLX 0.33%
- MIR N/A
- EPS Growth
- RLX 607.62
- MIR N/A
- EPS
- RLX 0.07
- MIR N/A
- Revenue
- RLX $307,798,132.00
- MIR $860,800,000.00
- Revenue This Year
- RLX $117.52
- MIR $6.97
- Revenue Next Year
- RLX $42.76
- MIR $7.88
- P/E Ratio
- RLX $32.89
- MIR N/A
- Revenue Growth
- RLX 99.79
- MIR 7.48
- 52 Week Low
- RLX $1.50
- MIR $9.11
- 52 Week High
- RLX $2.69
- MIR $18.81
- Technical
- Relative Strength Index (RSI)
- RLX 63.09
- MIR 43.93
- Support Level
- RLX $2.29
- MIR $15.93
- Resistance Level
- RLX $2.45
- MIR $17.24
- Average True Range (ATR)
- RLX 0.12
- MIR 0.75
- MACD
- RLX -0.00
- MIR 0.05
- Stochastic Oscillator
- RLX 50.00
- MIR 29.00
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.